Literature DB >> 17477824

Applications of RNA interference in mammalian systems.

Scott E Martin1, Natasha J Caplen.   

Abstract

RNA interference (RNAi) can mediate the long- or short-term silencing of gene expression at the DNA, RNA, and/or protein level. Although several triggers of RNAi have been identified, the best characterized of these are small interfering RNAs (siRNAs), which can decrease gene expression through mRNA transcript cleavage, and endogenous microRNAs (miRNAs), which primarily inhibit protein translation. An improved understanding of RNAi has provided new, powerful tools for conducting functional studies in a gene-specific manner. In various applications, RNAi has been used to create model systems, to identify novel molecular targets, to study gene function in a genome-wide fashion, and to create new avenues for clinical therapeutics. Here, we review many of the ongoing applications of RNAi in mammalian and human systems, and discuss how advances in our knowledge of the RNAi machinery have enhanced the use of these technologies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17477824     DOI: 10.1146/annurev.genom.8.080706.092424

Source DB:  PubMed          Journal:  Annu Rev Genomics Hum Genet        ISSN: 1527-8204            Impact factor:   8.929


  45 in total

1.  RNAi screening identifies TAK1 as a potential target for the enhanced efficacy of topoisomerase inhibitors.

Authors:  S E Martin; Z-H Wu; K Gehlhaus; T L Jones; Y-W Zhang; R Guha; S Miyamoto; Y Pommier; N J Caplen
Journal:  Curr Cancer Drug Targets       Date:  2011-10       Impact factor: 3.428

2.  Local inactivation of Gpr88 in the nucleus accumbens attenuates behavioral deficits elicited by the neonatal administration of phencyclidine in rats.

Authors:  M Ingallinesi; L Le Bouil; N Faucon Biguet; A Do Thi; C Mannoury la Cour; M J Millan; P Ravassard; J Mallet; R Meloni
Journal:  Mol Psychiatry       Date:  2014-08-26       Impact factor: 15.992

Review 3.  Nonviral delivery of synthetic siRNAs in vivo.

Authors:  Saghir Akhtar; Ibrahim F Benter
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

Review 4.  Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell.

Authors:  Georgia Sotiropoulou; Georgios Pampalakis; Evi Lianidou; Zissimos Mourelatos
Journal:  RNA       Date:  2009-06-26       Impact factor: 4.942

5.  Attenuated protein expression vectors for use in siRNA rescue experiments.

Authors:  Eiji Morita; Jun Arii; Devin Christensen; Jörg Votteler; Wesley I Sundquist
Journal:  Biotechniques       Date:  2012-08       Impact factor: 1.993

Review 6.  New short interfering RNA-based therapies for glomerulonephritis.

Authors:  Hideki Shimizu; Toshiro Fujita
Journal:  Nat Rev Nephrol       Date:  2011-05-24       Impact factor: 28.314

7.  RNAi targeting GPR4 influences HMEC-1 gene expression by microarray analysis.

Authors:  Juan Ren; Yuelang Zhang; Hui Cai; Hongbing Ma; Dongli Zhao; Xiaozhi Zhang; Zongfang Li; Shufeng Wang; Jiangsheng Wang; Rui Liu; Yi Li; Jiansheng Qian; Hongxia Wei; Liying Niu; Yan Liu; Lisha Xiao; Muyang Ding; Shiwen Jiang
Journal:  Int J Clin Exp Med       Date:  2014-03-15

Review 8.  Phenotypic screening with primary neurons to identify drug targets for regeneration and degeneration.

Authors:  Daniel J Cooper; Giulia Zunino; John L Bixby; Vance P Lemmon
Journal:  Mol Cell Neurosci       Date:  2016-07-18       Impact factor: 4.314

9.  Knowledge based identification of essential signaling from genome-scale siRNA experiments.

Authors:  Armand Bankhead; Iliana Sach; Chester Ni; Nolwenn LeMeur; Mark Kruger; Marc Ferrer; Robert Gentleman; Carol Rohl
Journal:  BMC Syst Biol       Date:  2009-08-05

10.  Efficient siRNA delivery by the cationic liposome DOTAP in human hematopoietic stem cells differentiating into dendritic cells.

Authors:  Sabata Martino; Ilaria di Girolamo; Roberto Tiribuzi; Francesco D'Angelo; Alessandro Datti; Aldo Orlacchio
Journal:  J Biomed Biotechnol       Date:  2009-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.